Fulveser 250Mg/5Ml Pfs Inj contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Fulveser 250Mg/5Ml Pfs Inj may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).

FAQs

How does Fulveser 250Mg/5Ml Pfs Inj work?

Fulveser 250Mg/5Ml Pfs Inj contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Is Fulveser 250Mg/5Ml Pfs Inj safe for patients with liver problems?

Fulveser 250Mg/5Ml Pfs Inj is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Fulveser 250Mg/5Ml Pfs Inj.

Does Fulveser 250Mg/5Ml Pfs Inj cause weakness?

Fulveser 250Mg/5Ml Pfs Inj may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.